PDS-0330
CAS No. 2904682-19-3
PDS-0330( —— )
Catalog No. M36554 CAS No. 2904682-19-3
PDS-0330 is a claudin-1 small molecule inhibitor inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 113 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 335 | In Stock |
|
| 50MG | 477 | In Stock |
|
| 100MG | 658 | In Stock |
|
| 200MG | 886 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePDS-0330
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDS-0330 is a claudin-1 small molecule inhibitor inhibitor.
-
DescriptionPDS-0330 is a specific and potent Claudin-1 inhibitor. PDS-0330 interferes with claudin-1/Src association and inhibits colorectal cancer (CRC) progression and metastasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2904682-19-3
-
Formula Weight423.49
-
Molecular FormulaC25H17N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 4 mg/mL (9.45 mM; Ultrasonic (<60°C)
-
SMILESN(C(NC(=O)C1=CC2=C(C=C1)C=CC=C2)=S)C3=CC=C(C4=NC=5C(O4)=CC=CC5)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fatima I, et al. Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis. Biomed Pharmacother. 2023 Mar;159:114255.?
molnova catalog
related products
-
L-allo-Threonine
Threonine is an essential amino acid in humans. It is abundant in human plasma particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness in experimental animals. Threonine is an immunostimulant which promotes the growth of thymus gland. It also can probably promote cell immune defense function.
-
Chondroitin 4-sulfat...
Chondroitin sulfate is an important structural component of cartilage and has been used as a dietary supplement for the treatment of joint discomfort.
-
Divarasib
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM.
Cart
sales@molnova.com